December 17, 2019 / 6:34 AM / a month ago

Roche has 60.4% of Spark, plans to wrap up takeover on Tuesday

FILE PHOTO: Swiss drugmaker Roche's logo is seen at their headquarters in Basel, Switzerland, January 28, 2016. REUTERS/Arnd Wiegmann

ZURICH (Reuters) - Swiss drugmaker Roche Holding (ROG.S) plans to complete on Tuesday its $4.3 billion takeover of Spark Therapeutics ONCE.O, it said, after winning U.S. regulatory approval for the long-delayed deal.

Roche said approximately 60.4% of the total number of shares of Spark’s common stock outstanding had been tendered in its offer for the gene therapy specialist.

Reporting by Michael Shields; editing by Thomas Seythal

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below